Application Note

Performance Comparison Of The Vericheck ddPCR™ Empty-Full Capsid Kit And Analytical Ultracentrifugation (AUC)

Scientist with DNA copying PCR cycler GettyImages-177381768

Ensuring the presence of the intended vector genome in adeno-associated virus (AAV) capsids is critical for their therapeutic effect. Current biophysical methods, such as analytical ultracentrifugation (AUC), treat all DNA within a capsid as equivalent, failing to identify problematic contaminant DNA. This application note delves into the precision of the Vericheck ddPCR Empty-Full Capsid Kit, which excels at measuring only the intended vector genome.

This capability provides a stronger correlation with overall product quality and safety, addressing a significant challenge in gene therapy manufacturing. To learn more about this innovative approach and its benefits, download the application note.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene